Figure 5: Histopathology Score
2019-06-11T07:08:25Z (GMT) by
Quantified cardiotoxicity grading (summed severity score) between controls (n = 5) and doxorubicin (DOX)-treated rats (n = 5) at 4 weeks, and controls (n = 5) and DOX-treated rats (n = 4) 8 weeks following chemotherapy initiation. *p < 0.05 between-group difference. Values are expressed as median with interquartile range.